Edelman Joseph's Form 4 filing
Aldeyra Therapeutics, Inc. (ALDX) · filed Apr 3, 2024
- Accession no.
- 0001062993-24-007959
- Filed
- Apr 3, 2024, 5:22 PM ET
- Trade date
- Apr 1-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.93M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | PPurchaseAcquired | +8,374 | $3.25 | +$27,215.5 | 8,601,960 | Indirect | |
| Apr 2, 2024 | Common Stock | PPurchaseAcquired | +186,051 | $3.44 | +$640,015.44 | 8,788,011 | Indirect | |
| Apr 3, 2024 | Common Stock | PPurchaseAcquired | +309,847 | $4.09 | +$1,267,274.23 | 9,097,858 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.